Clearstead Advisors’s Sensus Healthcare SRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding SRTS
PRCP
DSCM
S
GWM
NSIM
Clearstead Advisors's SRTS Position: Q2 2026 in Review
Clearstead Advisors sold out of Sensus Healthcare (SRTS) in Q2 2026, closing a stake of 155 shares — an estimated $617 sold.
Clearstead Advisors first reported a position in SRTS in Q4 2025 and held it in 2 quarters. The position peaked at $617 in Q1 2026. 38 funds tracked by Wall St. Rank hold SRTS as of Q2 2026.
- Clearstead Advisors reported no remaining Sensus Healthcare position as of Q2 2026 after selling out during the quarter.
- Clearstead Advisors sold 155 Sensus Healthcare shares in Q2 2026, an estimated $617.
- Clearstead Advisors first reported a position in Sensus Healthcare in Q4 2025 and held it in 2 quarters.
- Clearstead Advisors's Sensus Healthcare position peaked at $617 in Q1 2026.
- 38 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.